Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jerry Avorn

Showing results (291-300 of 308) with videos related to

Pageof 31
Sort By:
Health Affairs (Project Hope)|November 3, 2010
At Pitney Bowes, value-based insurance design cut copayments and increased drug adherenceNiteesh K Choudhry, Michael A Fischer, Jerry Avorn, et al.
JMIR Research Protocols|April 27, 2022
Overcoming Decisional Gaps in High-Risk Prescribing by Junior Physicians Using Simulation-Based Training: Protocol for a Randomized Controlled TrialJulie C Lauffenburger, Matthew F DiFrancesco, Renee A Barlev, et al.
American Journal of Obstetrics and Gynecology|March 22, 2016
Persistent opioid use following cesarean delivery: patterns and predictors among opioid-naïve womenBrian T Bateman, Jessica M Franklin, Katsiaryna Bykov, et al.
BMJ (Clinical Research Ed.)|March 19, 2015
Statins and congenital malformations: cohort studyBrian T Bateman, Sonia Hernandez-Diaz, Michael A Fischer, et al.
The New England Journal of Medicine|November 15, 2011
Full coverage for preventive medications after myocardial infarctionNiteesh K Choudhry, Jerry Avorn, Robert J Glynn, et al.
American Heart Journal|April 1, 2009
Rationale and design of the Study Assessing the Effect of Cardiovascular Medications Provided as Low-cost, Evidence-based Generic Samples (SAMPLES) trialWilliam H Shrank, Niteesh K Choudhry, Daniel H Solomon, et al.
Drug Safety|April 12, 2012
Early steps in the development of a claims-based targeted healthcare safety monitoring system and application to three empirical examplesPeter M Wahl, Joshua J Gagne, Thomas E Wasser, et al.
Pharmacoepidemiology and Drug Safety|August 8, 2013
Re-using Mini-Sentinel data following rapid assessments of potential safety signals via modular analytic programsSengwee Toh, Jerry Avorn, Ralph B D'Agostino, et al.
Medical Care|August 4, 2009
An evaluation of the relationship between the implementation of a newly designed prescription drug label at Target pharmacies and health outcomesWilliam H Shrank, Amanda Patrick, Patrick P Gleason, et al.
American Heart Journal|July 1, 2008
Rationale and design of the Post-MI FREEE trial: a randomized evaluation of first-dollar drug coverage for post-myocardial infarction secondary preventive therapiesNiteesh K Choudhry, Troyen Brennan, Michele Toscano, et al.
Pageof 31

Showing results (291-300 of 308) with videos related to

Sort By:
Pageof 31
Health Affairs (Project Hope)|November 3, 2010
At Pitney Bowes, value-based insurance design cut copayments and increased drug adherenceNiteesh K Choudhry, Michael A Fischer, Jerry Avorn, et al.
JMIR Research Protocols|April 27, 2022
Overcoming Decisional Gaps in High-Risk Prescribing by Junior Physicians Using Simulation-Based Training: Protocol for a Randomized Controlled TrialJulie C Lauffenburger, Matthew F DiFrancesco, Renee A Barlev, et al.
American Journal of Obstetrics and Gynecology|March 22, 2016
Persistent opioid use following cesarean delivery: patterns and predictors among opioid-naïve womenBrian T Bateman, Jessica M Franklin, Katsiaryna Bykov, et al.
BMJ (Clinical Research Ed.)|March 19, 2015
Statins and congenital malformations: cohort studyBrian T Bateman, Sonia Hernandez-Diaz, Michael A Fischer, et al.
The New England Journal of Medicine|November 15, 2011
Full coverage for preventive medications after myocardial infarctionNiteesh K Choudhry, Jerry Avorn, Robert J Glynn, et al.
American Heart Journal|April 1, 2009
Rationale and design of the Study Assessing the Effect of Cardiovascular Medications Provided as Low-cost, Evidence-based Generic Samples (SAMPLES) trialWilliam H Shrank, Niteesh K Choudhry, Daniel H Solomon, et al.
Drug Safety|April 12, 2012
Early steps in the development of a claims-based targeted healthcare safety monitoring system and application to three empirical examplesPeter M Wahl, Joshua J Gagne, Thomas E Wasser, et al.
Pharmacoepidemiology and Drug Safety|August 8, 2013
Re-using Mini-Sentinel data following rapid assessments of potential safety signals via modular analytic programsSengwee Toh, Jerry Avorn, Ralph B D'Agostino, et al.
Medical Care|August 4, 2009
An evaluation of the relationship between the implementation of a newly designed prescription drug label at Target pharmacies and health outcomesWilliam H Shrank, Amanda Patrick, Patrick P Gleason, et al.
American Heart Journal|July 1, 2008
Rationale and design of the Post-MI FREEE trial: a randomized evaluation of first-dollar drug coverage for post-myocardial infarction secondary preventive therapiesNiteesh K Choudhry, Troyen Brennan, Michele Toscano, et al.
Pageof 31